The Wockhardt Group, formerly a prominent player in the pharmaceutical industry, is facing financial difficulties. With mounting debts and a struggling business, the group's valuable assets are now being put up for grabs. This dramatic turn of events has sent shockwaves through the industry, spurring speculation within financial circles. It remain… Read More